AEHR

NEUTRALEarnings

Aehr Test Systems

Price
$107.21
+5.52%

This is the 2026-10-02 snapshot — the signals and analysis for AEHR as of this single trading day.

View full AEHR research hub →
Score9.5Priority
Signals4/8 DNA1/13 Act · 0/4 Risk
SentimentNEUTRALScore: 9
Volume0.8xvs 20d avg

Analysis

AEHR is experiencing High-Conviction Price Discovery following a blowout fiscal Q1 2027 earnings report that showcased a record $100 million backlog and strong traction in AI semiconductor testing. This fundamental catalyst perfectly validates the stock's bullish technical setup, triggering a Bollinger Squeeze that has resolved into a Perfect Stack and Steady Climb. In the current RISK_ON macro regime, the market is aggressively rewarding high-beta momentum plays, explaining AEHR's dominant +40.8% relative strength versus the SPY. With institutional buyers clearly absorbing shares on the AI growth narrative, conviction remains high as long as key support holds.

Fired Signals

STEADY CLIMBGOLDEN CROSSBOLLINGER SQUEEZEPERFECT STACKINSIDE OUT

Key Takeaways

  • Actionable Thesis: Ride the High-Conviction Price Discovery driven by AEHR's blowout Q1 earnings, massive $100M backlog, and strong alignment with AI semiconductor testing demand.
  • Key Risk: High execution risk exists due to historical cash burn; any delays in ramping up new AI and silicon photonics testing programs could trigger aggressive selling.
  • What to Watch: Price action around the $81.58 structural support level, which must hold to maintain the current Perfect Stack and Steady Climb technical structure.
© 2026 Signal52 • For educational purposes only